A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Gustave Roussy, Cancer Campus, Grand Paris
Thomas Jefferson University
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Goethe University
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
AIDS Malignancy Consortium
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Children's Oncology Group
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
SWOG Cancer Research Network
University of California, San Francisco
Northside Hospital, Inc.
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital